BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 29391779)

  • 1. Biological activity, quantitative structure-activity relationship analysis, and molecular docking of xanthone derivatives as anticancer drugs.
    Miladiyah I; Jumina J; Haryana SM; Mustofa M
    Drug Des Devel Ther; 2018; 12():149-158. PubMed ID: 29391779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. QSAR and docking studies on xanthone derivatives for anticancer activity targeting DNA topoisomerase IIα.
    Alam S; Khan F
    Drug Des Devel Ther; 2014; 8():183-95. PubMed ID: 24516330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative structure-activity relationship (QSAR) and molecular docking of xanthone derivatives as anti-tuberculosis agents.
    Yuanita E; Sudirman ; Dharmayani NKT; Ulfa M; Syahri J
    J Clin Tuberc Other Mycobact Dis; 2020 Dec; 21():100203. PubMed ID: 33294629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent cancer drug development with xanthone structures.
    Na Y
    J Pharm Pharmacol; 2009 Jun; 61(6):707-12. PubMed ID: 19505360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Xanthone Conjugated Amino Acids as Potential Anticancer and DNA Binding Agents: Molecular Docking, Cytotoxicity and SAR Studies.
    Rakesh KP; Darshini N; Manukumar HM; Vivek HK; Eissa MYH; Prasanna DS; Mallesha N
    Anticancer Agents Med Chem; 2018; 18(15):2169-2177. PubMed ID: 30179146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Xanthones for melanogenesis inhibition: Molecular docking and QSAR studies to understand their anti-tyrosinase activity.
    Rosa GP; Palmeira A; Resende DISP; Almeida IF; Kane-Pagès A; Barreto MC; Sousa E; Pinto MMM
    Bioorg Med Chem; 2021 Jan; 29():115873. PubMed ID: 33242700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular Docking, G-QSAR Studies, Synthesis and Anticancer Screening of Some New 2-Phenazinamines as Bcr-Abl Tyrosine Kinase Inhibitors.
    Kale MA; Sonwane GM
    Curr Drug Discov Technol; 2020; 17(2):213-224. PubMed ID: 30210004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Virtual screening, Docking, ADMET and System Pharmacology studies on Garcinia caged Xanthone derivatives for Anticancer activity.
    Alam S; Khan F
    Sci Rep; 2018 Apr; 8(1):5524. PubMed ID: 29615704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prenylated xanthones and benzophenones from the fruits of Garcinia bracteata and their potential antiproliferative and anti-inflammatory activities.
    Xue Q; Chen Y; Yin H; Teng H; Qin R; Liu H; Li Q; Mei Z; Yang G
    Bioorg Chem; 2020 Nov; 104():104339. PubMed ID: 33142411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis of xanthone derivatives based on α-mangostin and their biological evaluation for anti-cancer agents.
    Fei X; Jo M; Lee B; Han SB; Lee K; Jung JK; Seo SY; Kwak YS
    Bioorg Med Chem Lett; 2014 May; 24(9):2062-5. PubMed ID: 24717154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis of Novel Xanthone Analogues and Their Growth Inhibitory Activity Against Human Lung Cancer A549 Cells.
    Wu J; Dai J; Zhang Y; Wang J; Huang L; Ding H; Li T; Zhang Y; Mao J; Yu S
    Drug Des Devel Ther; 2019; 13():4239-4246. PubMed ID: 31853172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytotoxic and Anti-Inflammatory Activities of Dihydroisocoumarin and Xanthone Derivatives from
    Sukandar ER; Kaennakam S; Raab P; Nöst X; Rassamee K; Bauer R; Siripong P; Ersam T; Tip-Pyang S; Chavasiri W
    Molecules; 2021 Nov; 26(21):. PubMed ID: 34771035
    [No Abstract]   [Full Text] [Related]  

  • 13. Design, synthesis and biological evaluation of novel 1-hydroxyl-3-aminoalkoxy xanthone derivatives as potent anticancer agents.
    Yang ZM; Huang J; Qin JK; Dai ZK; Lan WL; Su GF; Tang H; Yang F
    Eur J Med Chem; 2014 Oct; 85():487-97. PubMed ID: 25113877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis, inhibitory activities, and QSAR study of xanthone derivatives as alpha-glucosidase inhibitors.
    Liu Y; Ke Z; Cui J; Chen WH; Ma L; Wang B
    Bioorg Med Chem; 2008 Aug; 16(15):7185-92. PubMed ID: 18632275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Docking-assisted 3D-QSAR studies on xanthones as α-glucosidase inhibitors.
    Zheng X; Zhou S; Zhang C; Wu D; Luo HB; Wu Y
    J Mol Model; 2017 Aug; 23(9):272. PubMed ID: 28861624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytotoxic and α-Glucosidase Inhibitory Xanthones from Garcinia mckeaniana Leaves and Molecular Docking Study.
    Thi Thu HN; Minh QP; Van CP; Van TN; Van KP; Thanh TN; Le Thi Tu A; Litaudon M; The SN
    Chem Biodivers; 2021 Nov; 18(11):e2100396. PubMed ID: 34529335
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel benzothiazole-based dual VEGFR-2/EGFR inhibitors targeting breast and liver cancers: Synthesis, cytotoxic activity, QSAR and molecular docking studies.
    Abd El-Meguid EA; Naglah AM; Moustafa GO; Awad HM; El Kerdawy AM
    Bioorg Med Chem Lett; 2022 Feb; 58():128529. PubMed ID: 35007724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytotoxic activity and DNA-binding properties of xanthone derivatives.
    Shen R; Wang P; Tang N
    J Fluoresc; 2010 Nov; 20(6):1287-97. PubMed ID: 20532595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of New Synthetic Xanthones on the Proliferation and Migration Potential of Cancer Cell Lines In Vitro.
    Szkaradek N; Sypniewski D; Żelaszczyk D; Gałka S; Borzdziłowska P; Marona H; Bednarek I
    Anticancer Agents Med Chem; 2019; 19(16):1949-1965. PubMed ID: 30950354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of New Pyrazolopyridine, Furopyridine, and Pyridine Derivatives as CDK2 Inhibitors: Design, Synthesis, Docking Studies, and Anti-Proliferative Activity.
    Abdel-Rahman AA; Shaban AKF; Nassar IF; El-Kady DS; Ismail NSM; Mahmoud SF; Awad HM; El-Sayed WA
    Molecules; 2021 Jun; 26(13):. PubMed ID: 34206976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.